EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer

Anna McCracken, Olivia R Grafinger, Hon S Leong, Ana Elisa Lohmann, Katarzyna J Jerzak, Sunit Das

Cancer Treatment Reviews · 2026-03 · 144 · 103111

DOI: 10.1016/j.ctrv.2026.103111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-03. Verfasst von Anna McCracken und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto Institute of Medical Science, Toronto, Canada. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neoadjuvant Therapy, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeoadjuvant TherapyBreast NeoplasmsHumansFemaleNeoplastic Cells, CirculatingNeoplasm MetastasisCirculating Tumor DNA

Stichwörter der Autor:innen

Biomarker-guided risk stratificationBreast cancer metastasisCirculating tumour DNACirculating tumour cellsDisseminated cancer cellsLiquid biopsyNeoadjuvant therapy

Substanzen

Biomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • University of Toronto Institute of Medical Science, Toronto, Canada.
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
  • Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; University of Toronto Department of Medical Biophysics, Toronto, Canada.
  • Department of Oncology and Epidemiology, University of Western Ontario, London, Canada.
  • University of Toronto Institute of Medical Science, Toronto, Canada; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada; Division of Medical Oncology, Sunnybrook Hea…
  • University of Toronto Institute of Medical Science, Toronto, Canada; Division of Neurosurgery, St. Michael's Hospital, University of Toronto, Toronto, Canada. Electronic address: sunit.das@utoronto.ca.

Zitieren

APA

McCracken, A., Grafinger, O. R., Leong, H. S., Lohmann, A. E., Jerzak, K. J., & Das, S. (2026). Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer. Cancer Treatment Reviews, 144, 103111. https://doi.org/10.1016/j.ctrv.2026.103111

Vancouver

McCracken A, Grafinger OR, Leong HS, Lohmann AE, Jerzak KJ, Das S. Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer. Cancer Treatment Reviews. 2026;144:103111. doi:10.1016/j.ctrv.2026.103111

BibTeX
@article{McCracken2026,
  author = {McCracken, Anna and Grafinger, Olivia R and Leong, Hon S and Lohmann, Ana Elisa and Jerzak, Katarzyna J and Das, Sunit},
  title = {Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {144},
  pages = {103111},
  doi = {10.1016/j.ctrv.2026.103111}
}
Kostenlos starten →